
    
      This study will combine two drugs (hydroxychloroquine and Bromhexine) to see if
      hydroxychloroquine is better in combination with Bromhexine in preventing the development of
      the disease from COVID-19 in Health Care Workers at a National Institute of Health In Mexico
      City. Hydroxychloroquine will be used in a low dose (200 mg every 24 hrs). Bromhexine will be
      8mg every 8 hrs. The study groups will be the following: 1) HCQ 200mg/d + BHH placebo 2) HCQ
      placebo plus BHH placebo
    
  